WHO rules have to have manufacturers to apply a constant danger management course of action for sterility test isolators, like normal threat assessments and the development of risk-primarily based Management methods. Manufacturers seeking to carry out these methods will have to supply robust validation facts to exhibit their equivalence Successfully Submitted (Awaiting Approval)